GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$90.18
+2.72% today
Updated 2026-04-30
Market cap
$11.91B
P/E ratio
22.40
P/S ratio
4.05x
EPS (TTM)
$3.92
Dividend yield
—
52W range
$52 – $101
Volume
1.1M
Globus Medical (GMED) Financial statements
SEC filings — annual and quarterly data.
Profit margin
18.30%
Operating margin
24.40%
ROE
12.30%
ROA
7.11%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | $254.34M | $48.73M | 83.64% | 32.20% | 19.16% |
| 2010 | $288.19M | $54.46M | 81.32% | 30.43% | 18.90% |
| 2011 | $331.48M | $60.78M | 79.25% | 29.37% | 18.34% |
| 2012 | $385.99M | $73.83M | 80.52% | 29.74% | 19.13% |
| 2013 | $434.46M | $68.61M | 76.90% | 23.40% | 15.79% |
| 2014 | $474.37M | $92.48M | 76.65% | 29.17% | 19.50% |
| 2015 | $544.75M | $112.78M | 75.71% | 31.61% | 20.70% |
| 2016 | $563.99M | $104.34M | 76.12% | 27.33% | 18.50% |
| 2017 | $635.98M | $107.35M | 76.34% | 25.45% | 16.88% |
| 2018 | $712.97M | $156.47M | 77.64% | 23.75% | 21.95% |
| 2019 | $785.37M | $155.21M | 77.08% | 21.90% | 19.76% |
| 2020 | $789.04M | $102.28M | 72.44% | 14.12% | 12.96% |
| 2021 | $958.10M | $149.19M | 75.03% | 17.95% | 15.57% |
| 2022 | $1.02B | $190.17M | 74.22% | 22.29% | 18.59% |
| 2023 | $1.57B | $122.87M | 65.05% | 8.49% | 7.83% |
| 2024 | $2.52B | $102.98M | 58.90% | 6.59% | 4.09% |
| 2025 | $2.94B | $537.90M | 67.41% | 16.33% | 18.30% |